B2B 24-7 Mobile Drug Testing Franchise! Raking in National Account Rev
AI-Resistant B2B Medical Franchise | National Accounts | NO-Labor 1099 Model
$1,100,000
EBITDA: $300,000
$1,100,000
EBITDA: $300,000

$250,000
$250,000

$500,000
Cash Flow: $270,666
$500,000
Cash Flow: $270,666
Cash Flow: $397,895
Cash Flow: $397,895
